$44.22
3.01%
Nasdaq, Oct 07, 04:17 pm EDT. Closed.
ISIN
US74768A1043
Symbol
QNT

Quantinuum Stock price

$44.22
-5.43 10.94% 1M
-15.78 26.30% 6M
-15.78 26.30% YTD
-15.78 26.30% 1Y
-15.78 26.30% 3Y
-15.78 26.30% 5Y
-15.78 26.30% 10Y
-15.78 26.30% 20Y
Nasdaq, Closing price Wed, Oct 07 2026
-1.37 3.01%
ISIN
US74768A1043
Symbol
QNT
Industry

Is Quantinuum a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,113 stocks worldwide.

Key metrics

Basic
Market capitalization
$11.6b
Enterprise Value
$9.5b
Net debt
positive
Cash
$2.1b
Shares outstanding
32.9m
Valuation
P/E
negative
P/S | estimate
263.6 | 382.7
EV/Sales | estimate
215.8 | 313.3
EV/FCF | ex SBC
negative | negative
P/B
28.2
Financial Health
Equity Ratio
91.4%
Return on Equity
-11.4%
ROCE
-26.9%
ROIC
-77.6%
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$447.5m | 1,013.0%
SBC as % of FCF
-
SBC Growth 1Y
-
Share Count Growth 1Y
-
Shareholder Yield
-
Financials
Revenue | estimate
$44.2m | $30.4m
EBITDA
$-811.8m
EBIT
$-831.5m
Net Income
$-394.6m
Free Cash Flow | ex SBC
$-355.5m | $-802.9m
Growth
Revenue | estimate
- | -1.6%
EBITDA
-
EBIT
-
Net Income
-
Free Cash Flow
-
Margin
Gross
63.4%
EBITDA
-1,837.9%
EBIT
-1,882.6%
Net
-893.4%
Free Cash Flow | ex SBC
-804.8% | -1,818.0%
More
EPS
$-12.0
FCF per Share
$-10.8
Short interest
8.0%
Employees
-
Rev per Employee
-

Quantinuum Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Quantinuum forecast:

15x Buy
88%
2x Hold
12%

Analyst Opinions

17 Analysts have issued a Quantinuum forecast:

Buy
88%
Hold
12%

Financial data from Quantinuum

Jun '26
+/-
%
44 44
-
100%
- Direct Costs 16 16
-
37%
28 28
-
63%
- Selling and Administrative Expenses 252 252
-
571%
- Research and Development Expense 587 587
-
1,330%
-812 -812
-
-1,838%
- Depreciation and Amortization 20 20
-
45%
EBIT (Operating Income) EBIT -831 -831
-
-1,882%
Net Profit -395 -395
-
-893%

In millions USD.

Don't miss a Thing! We will send you all news about Quantinuum directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quantinuum Stock News

Neutral
PRNewsWire
●
3 days ago
Quantinuum and The University of Western Australia (UWA) sign MOU to help prepare Australia's workforce and innovation ecosystem for the hybrid quantum-AI-HPC computing era Quantinuum will provide UWA-affiliated researchers, students and entrepreneurs with access to its full-stack quantum computing ecosystem, including Helios, the world's most accurate commercial quantum computer1 Collaboration...
Neutral
Market Watch
●
15 days ago
This week's Quantum World Congress could trigger a ‘sentiment reversal' for quantum stocks after a rough summer, an analyst said.
Neutral
Barrons
●
20 days ago
The U.S. Energy Department launches Quantum Genesis Q, a competition to build an error-corrected, ‘scientifically relevant' quantum computer.

Company Profile

Quantinuum Inc is a US-based company operating in IT Services industry. The company is headquartered in Broomfield, Colorado and currently employs 679 full-time employees. The company went IPO on 2026-06-04. Quantinuum Inc. is a provider of quantum computing platform, which offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property. The firm's vertically integrated quantum computing platform combines quantum hardware systems and middleware with application software designed to make quantum computing deployable in real-world environments built on the Quantum Charge‑Coupled Device architecture. Its products and solutions include Quantinuum Systems, Helios, Quantum Origin, InQuanto and Nexus. Nexus is a quantum computing platform for accessing and managing performance full stack. InQuanto is a quantum computational chemistry for complex molecular and materials simulations. Quantum Origin is a quantum random number generator designed for encryption and protect data. Its developer tools include TKET, Guppy and Lambeq. The company operates across pharmaceuticals, materials science, financial services, government and industrial markets.

Head office United States
Website www.quantinuum.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today